Behavioral Neuroscience – Products

Integration of Nova’s BioProfile® FLEX2 will enable automated cell culture analyses for process development through commercial manufacturing with Quantum Flex.

DNAnexus, Inc., provider of the Precision Health Data Cloud, and Galatea Bio, committed to 'Precision Health at Scale for All,' announced a strategic collaboration to enhance biomedical research and precision medicine.

On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.

Delve into this case study to explore how a research lab at King’s College London used hiPSC-derived neurons to shed light on synaptic biology and potential treatments for psychiatric conditions.

Curio Bioscience licenses a novel method from the Broad Institute of MIT and Harvard to fuel the next generation of discovery research.

Newly-launched module set to accelerate drug discovery in therapeutic areas such as neuropsychiatry, epilepsy and neurodegeneration.

An analysis of NHS prescriptions data has revealed the huge potential for pharmacogenomics to reduce ineffective prescribing and adverse effects, which could save millions of pounds for the NHS.

Discover ioGABAergic Neurons from bit.bio and avoid unwanted excitatory neurons obscuring inhibitory signals in your experiments. Using a simple protocol, consistently go from cryopreserved cells to mature, functional, experiment-ready hiPSC-derived GABAergic neurons with >95% purity in 12 days.

In 2012, the Harvard Brain Tissue Resource Center lost 150 of its stored frozen brain samples, including one third of the world’s largest collection of autism brain tissue.

Blackrock Neurotech revealed its next-generation neural interface, Neuralace™, at Society for Neuroscience 2022.